Polygenic risk score: a tool ready for clinical use?

M. Kavousi*, H. Schunkert

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)1712-1714
Number of pages3
JournalEuropean Heart Journal
Issue number18
Publication statusPublished - 7 May 2022

Bibliographical note

Funding Information:
The authors wish to thank Dr Fabian Starnecker for help with the figure. M.K. acknowledges support from the Dutch Heart Foundation (Senior Scientist grant: 03-004-2021-T050). H.S. acknowledges support from the Foundation Leducq (PlaqueOmics: Novel Roles of Smooth Muscle and Other Matrix Producing Cells in Atherosclerotic Plaque Stability and Rupture,18CVD02; CADgenomics: Understanding CAD Genes, 12CVD02) and the European Union under grant agreement HEALTH-F2-2013-601456 (CVgenes-at-target). He received grants for a British Heart Foundation (BHF)–German Center of Cardiovasular Research (DZHK) collaboration and the ERA-NET (Druggable-MI-Genes: 01KL1802), and was also supported by grants from the Federal German Ministries (AbCD-Net, grant 01ZX1706C; BLOCK-CAD, grant 16GW0198K; ModulMax, grant ZF4590201BA8), and the DFG as part of the Sonderforschungsbereich CRC 1123 (B2), the Transregio TRR 267 (B05), as well as the DigiMed Bayern project (DBM-1805-0001).

Cite this